Search
for

    Did you mean Dermatologic Adverse Events?
    GlossaryCutaneous Side Effects (Dermatologic Adverse Events)

    ...skin reactions caused by medications or treatments

    Cutaneous side effects refer to adverse reactions that affect the skin as a result of medication, treatment, or other external factors. These can include rashes, itching, redness, and more severe conditions like blistering or peeling. For professionals, understanding these side effects is crucial for diagnosing and managing patient care, especially in treatments involving chemotherapy or immunotherapy, which are known to cause significant skin reactions.

    Related Terms

    Learn

    5 / 5 results

      learn Tretinoin

      the gold standard retinoid in dermatology that's also helpful for hair regrowth alongside Minoxidil

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn Hydrocortisone

      a synthetic cortisol used for anti-inflammatory effects

      learn Bimatoprost

      a synthetic prostamide used to treat eyelashes also shows promise for stimulating hair growth on scalp

    Research

    5 / 1000+ results

    Community Join

    5 / 37 results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.